ADIL News and Press, Adial Pharmaceuticals Inc From 08/06/25

Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the Positive FDA Meeting GLEN ALLEN, Va., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the ȁ...

2025-07-30 14:30:42 ET FuboTV Pops 22% on Strong Q2 Results and First Positive EBITDA FuboTV Inc. ( FUBO ) soared 22.03%, leading the PRISM Emerging Sports Index , after releasing upbeat preliminary Q2 2025 results . The streaming platform exceeded revenue and subscriber...

2025-07-28 14:30:40 ET Sidus Space Falls 41% Following $7.5M Public Offering Announcement Sidus Space, Inc. ( SIDU ) plummeted 41.33%, dragging down the PRISM Emerging Space Index , after pricing a $7.5 million public offering of 7.14 million shares at $1.05 each . The off...

2025-07-28 11:12:31 ET DENVER, Colo., Jul 28, 2025 ( 247marketnews.com )- The biotech sector is buzzing with momentum as companies push into late-stage clinical trials, sign landmark agreements, and commercialize novel platforms. Kraig Biocraft Laboratories (OTCQB:KBLB) is pione...